Make Business Spectator my home

1. Drag the "B" and drop it onto your home button.
2. Select "Yes" from the pop up window.
3. Click on the red X to close this window.

• Federal Budget
• Advertising & Marketing
• Agribusiness
• Automotive
• Aviation
• Construction & Engineering
• Financial Services
• Food & Beverages
• Health & Pharmaceuticals
• HR & Education
• Infrastructure
• Insurance
• IT
• Leisure & Gaming
• Manufacturing
• Media & Internet
• Professional Services
• Property
• Resources & Energy
• Retail
• Telecommunications
• Transport & Logistics

• Climate Change
• Politics & IR
• Economy
• Financial Markets

• Appointments
• Shareholder notices
• Director Dealings

What’s New

• Investors should review their portfolios now before reality bites

Fermiscan breast cancer test accuracy confirmed

TOP News

• Westpac offers $18.6bn for St George

   5:48 PM

• Local stocks dip

   4:48 PM

• Swan to hand down first budget today

   1:43 AM

• WTO says trade deal possible in 2008

   4:49 PM

• BHP's Petroleum chief says looking for acquisitions

   2:42 PM

The Spectators

• Bartholomeusz: Crashing the wedding

• The pain behind HSBC's gain

• Kohler: Best laid plans

• Bartholomeusz: A glass-half-full merger

• Gottliebsen: The customer is always right

Source: News Bites

Fermiscan Holdings has confirmed the ability of its Fermiscan test to detect the presence of breast cancer using x-ray diffraction of hair.

Accuracy of 69% was achieved, and by exclusion of patients whose hair was subsequently analysed and independently confirmed as having been treated and damaged, the accuracy is 75%.

The trial included 2,000 patients.

Fermiscan will now progress to commercialisation of the test in Australia in 2008.

Share This Story

---

Related Industry Sectors

View the latest stories on Financial Services

Related Companies

View all stories on FERMISCAN HOLDINGS

---